Patents by Inventor Hans Wagner

Hans Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200180966
    Abstract: Triphenylgermylsilane (Ph3Ge—SiH3) is useful for the production of germanium-silicon layers (Ge—Si) or as transfer agent of silane groups (SiH3). Further, a method describes the production of triphenylgermylsilane (Ph3Ge—SiH3) by reducing trichlorosilyltriphenylgermane (Ph3Ge—SiCl3) with a hydride in solution, and another method describes the production of trichlorosilyltrichlorogermane (C3Ge—SiCl3) by reacting trichlorosilyltriphenylgermane (Ph3Ge—SiCl3) with hydrogen chloride (HCl) in the presence of AlCl3 in solution. In addition, trichlorosilyltrichlorogermane is also used for the production of germanium-silicon layers (Ge—Si).
    Type: Application
    Filed: May 23, 2018
    Publication date: June 11, 2020
    Applicant: Evonik Operations GmbH
    Inventors: Julian Teichmann, Matthias Wagner, Hans-Wolfram Lerner
  • Publication number: 20200165278
    Abstract: A trichlorogermanide of formula (I): [R4N]/[R4P]Cl[GeCl3] (I), where R is Me, Et, iPr, nBu, or Ph, tris(trichlorosilyl)germanide of formula (II): [R4N]/[RrP][Ge(SiCl3)3] (II), where R is Me, Et, iPr, nBu, or Ph, a tris(trichlorosilyl)germanide adduct of GaCl3 of formula (III): [Ph4P][Ge(SiCl3)3*GaCl3], and a tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV): [Ph4P][Ge(SiCl3)3*BBr3]. Also, methods for preparing the trichlorogermanides of formula (I), the tris(trichlorosilyl)germanide of formula (II), the tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV).
    Type: Application
    Filed: January 28, 2020
    Publication date: May 28, 2020
    Applicant: Evonik Degussa GmbH
    Inventors: Julian Teichmann, Matthias Wagner, Hans-Wolfram Lerner
  • Publication number: 20200155603
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 21, 2020
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Publication number: 20200145502
    Abstract: A method includes: (a) setting up a service orchestration rule set between a home operator and a sponsor service provider, managing a service domain for obtaining a data structure for a service definition object; (b) receiving a list of available services from the sponsor service provider; (c) receiving a subscriber selection of at least one service from the list; (d) adding a first set of data including subscriber specific data to the service definition object; (e) sending a service creation request to the sponsor service provider for subscribing to the selected service; and (f) receiving a response from the sponsor service provider including the service definition object complemented with a second set of data to allow the selected service to be executed.
    Type: Application
    Filed: June 12, 2018
    Publication date: May 7, 2020
    Inventors: Hans-Ruodi BURCH, Raphael AEBERSOLD, Ulrich HOSTETTLER, Frank-Peter JOST, Pierre-André ROUBATY, Christof WAGNER
  • Patent number: 10639332
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: May 5, 2020
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Patent number: 10639331
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: May 5, 2020
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Patent number: 10618921
    Abstract: A trichlorogermanide of formula (I): [R4N]/[R4P]Cl[GeCl3] (I), where R is Me, Et, iPr, nBu, or Ph, tris(trichlorosilyl)germanide of formula (II): [R4N]/[R4P][Ge(SiCl3)3] (II), where R is Me, Et, iPr, nBu, or Ph, a tris(trichlorosilyl)germanide adduct of GaCl3 of formula (III): [Ph4P][Ge(SiCl3)3*GaCl3], and a tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV): [Ph4P][Ge(SiCl3)3*BBr3]. Also, methods for preparing the trichlorogermanides of formula (I), the tris(trichlorosilyl)germanide of formula (II), the tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV).
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: April 14, 2020
    Assignee: Evonik Operations GmbH
    Inventors: Julian Teichmann, Matthias Wagner, Hans-Wolfram Lerner
  • Patent number: 10619671
    Abstract: A rolling-element bearing cage includes a first side ring and a second side ring connected to the first side ring by a plurality of bridges defining a plurality of pockets configured to receive a rolling-element. The first side ring includes a joint at which the first side ring is configured to be opened to increase a diameter of the first side ring, and the first side ring and the second side ring and the plurality of bridges are made of steel and an outer diameter of the second side ring is greater than 500 mm.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: April 14, 2020
    Assignee: AKTIEBOLAGET SKF
    Inventors: Berthold Beyfuss, Hans-Juergen Friedrich, Sabine Hofmann, Holger Kristandt, Alfred Radina, Jonas Schierling, Gerhard Wagner
  • Patent number: 10612957
    Abstract: A sensor system for determining at least one parameter of a fluid medium flowing through a channel, in particular of an intake air mass flow of an internal combustion engine. The sensor system includes a sensor housing, in particular a plug-in sensor, which is introduced or introducible into a flow tube in which the channel is formed, and at least one sensor chip, which is situated in the channel for determining the parameter of the fluid medium. The sensor housing includes a housing body and a cover. The channel has an inlet into the channel, which faces in a direction opposite the main flow direction of the fluid medium, and at least one outlet out of the channel. The channel is formed in the cover, and the cover is connected to the housing body with the aid of a force-locked connection.
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: April 7, 2020
    Assignee: Robert Bosch GmbH
    Inventors: Andreas Kaufmann, Hans Beyrich, Torsten Mais, Ulrich Wagner
  • Patent number: 10598224
    Abstract: A bearing cage segment for a rolling-element bearing includes at least one sliding surface on which a surface of at least one rolling element of the rolling-element bearing is rotatable, a first support element, such as an axial projection on an axial side of the cage segment having a radially open radially facing channel, at a first radial position for supporting a first band section of a band clamp during an assembling of the rolling-element bearing, and at least one second support element at a second radial position different from the first radial position for supporting a second band section of the band clamp.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: March 24, 2020
    Inventors: Hans-Juergen Friedrich, Alfred Radina, Juergen Reichert, Gerhard Wagner
  • Patent number: 10568909
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: February 25, 2020
    Assignee: Immatics Biotechnologies GmbH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Publication number: 20200052965
    Abstract: A method for operation of a central office point of delivery includes: in response to a pluggable interface module being plugged into an access node port of a line termination node of the central office point of delivery, transmitting, by the line termination node, a request message to a control node of the central office point of delivery, wherein the request message comprises interface module information related to the pluggable interface module, and wherein an activation clearance is requested, via the request message, from the control node; receiving, by the line termination node, from the control node, an acknowledgement message related to the activation clearance requested by the request message, wherein the acknowledgement message corresponds to a verification operation and/or activation clearance operation having been successful; and activating, by the line termination node and/or by the access port node, the pluggable interface module.
    Type: Application
    Filed: February 5, 2018
    Publication date: February 13, 2020
    Inventors: Thomas HAAG, Paul WAGNER, Hans-Joerg KOLBE, Robert SOUKUP, Manuel PAUL
  • Publication number: 20200038203
    Abstract: A prosthesis cosmetic element for a prosthesis comprising a prosthesis joint which has an upper part and a lower part that is mounted thereon in a pivotal manner about a pivot axis, the prosthesis cosmetic element has a first frame part, which has at least one first securing device for fixing on the lower part, and a second frame part with at least one second securing device for securing on the upper part. The frame parts are mounted in a pivotal manner relative to each other, and the prosthesis joint is equipped with a rotational element on which an actuating element is arranged. The actuating element is accessible from the outside by a frame part or through a frame part.
    Type: Application
    Filed: September 20, 2017
    Publication date: February 6, 2020
    Applicant: Otto Bock Healthcare Products GmbH
    Inventors: Markus PILLER, Hans OPPEL, Sonja WAGNER, Johannes BISCHOF, Alice FREY, Raphael SCHEFFEL, Walter LUNZER, Mario KOPPE, Andreas LEINIGER
  • Publication number: 20200000849
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 2, 2020
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Publication number: 20200000850
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 2, 2020
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Publication number: 20190381103
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: August 30, 2019
    Publication date: December 19, 2019
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Patent number: 10463696
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: November 5, 2019
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Patent number: 10460485
    Abstract: Disclosed herein are system, method, and computer program product embodiments for generating and adjusting multi-dimensional data visualizations. An embodiment operates by a computer implemented method that includes evaluating, by at least one processor, data to be displayed on a multi-dimensional data visualization and information associated with the multi-dimensional data visualization. The method further includes determining one or more parameters for the multi-dimensional data visualization based on the evaluated data and the evaluated information. The method further includes generating the multi-dimensional data visualization based on the determined one or more parameters, where the multi-dimensional data visualization comprises at least four dimensions. The method also includes graphically displaying the multi-dimensional data visualization.
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: October 29, 2019
    Assignee: SAP SE
    Inventors: Malin Wittkopf, Anca Maria Florescu, Christina Hall, Tatjana Borovikov, Guido Wagner, Klaus Herter, Felix Harling, Christian Knirsch, Christian Grail, Bogdan Alexander, Joachim Fiess, Hergen Siefken, Hee Tatt Ooi, Hans-Juergen Richstein, Marita Kruempelmann, Ingo Rues
  • Patent number: 10435373
    Abstract: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: October 8, 2019
    Assignees: LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN, MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Armin Giese, Uwe Bertsch, Hans Kretzschmar, Matthias Habeck, Thomas Hirschberger, Paul Tavan, Christian Griesinger, Andrei Leonov, Sergey Ryazanov, Petra Frick née Weber, Markus Geissen, Martin H. Groschup, Jens Wagner
  • Patent number: 10414783
    Abstract: A novel compound chlorosilylarylgermane, a method for preparing the compound, and the use of the compound are described. A method for preparing trichlorosilyltrichlorogermane and the use of trichlorosilyltrichlorogermane are also described.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: September 17, 2019
    Assignee: Evonik Degussa GmbH
    Inventors: Julian Teichmann, Matthias Wagner, Hans-Wolfram Lerner